Lung Disease News - Lung Disease News

Time 2020-09-16 17:08:47

Web Name: Lung Disease News - Lung Disease News

WebSite: http://lungdiseasenews.com

ID:48884

Keywords:

Lung,Disease,News,

Description:

PBI-4050, Prometic Life Sciences  lead small molecule therapy candidate, targets a new antifibrotic pathway involving two receptors that play ... Read more With the exception of using supplemental oxygen, pulmonary fibrosis (PF) is an invisible disease for the most part. Like ... Read more Researchers found that an enzyme previously linked only to cell metabolism is capable of reaching the nucleus of lung ... Read more When the only “known” cure for idiopathic pulmonary fibrosis (IPF) is removing the diseased lungs and replacing them ... Read more An investigative drug developed by Kadmon called KD025 was shown to be safe and effective to prevent lung function decline in ... Read more Women who use only short-acting asthma medications take longer to become pregnant than non-asthmatic women or women taking ... Read more The Pulmonary Fibrosis News forums launched a week ago! Many members have shared the PF forums with their ... Read more The digital healthcare company patientMpower expressed disappointment at the opinion issued by an influential U.K. healthcare advisory group to limit ... Read more The U.S. Food and Drug Administration (FDA) has approved the third targeted therapy developed by Vertex Pharmaceuticals for patients ... Read more PBI-4050, Prometic Life Sciences  lead small molecule therapy candidate, targets a new antifibrotic pathway involving two receptors that play opposite roles in fibrosis development, ... Read more Researchers found that an enzyme previously linked only to cell metabolism is capable of reaching the nucleus of lung fibroblasts and once there, halting ... Read more An investigative drug developed by Kadmon called KD025 was shown to be safe and effective to prevent lung function decline in patients with idiopathic pulmonary ... Read more Women who use only short-acting asthma medications take longer to become pregnant than non-asthmatic women or women taking long-acting medications, a new international ... Read more Asthma costs the U.S. economy nearly $82 billion a year, say researchers at the Centers for Disease Control and Prevention (CDC). Using data ... Read more The European Commission has approved Fasenra (benralizumab) as an add-on maintenance treatment in patients with severe eosinophilic asthma. The approval, announced by therapy developer AstraZeneca and its global research ... Read more The U.S. Food and Drug Administration has given Aradigm a list of suggestions for resubmitting an application for regulatory review of its bronchiectasis therapy Linhaliq. A ... Read more The Antimicrobial Drugs Advisory Committee (ADAC) of the U.S. Food and Drug Administration (FDA) did not recommend approval of Aradigm’s Linhaliq for the treatment ... Read more A committee of the U.S. Food and Drug Administration (FDA) will meet next month to review an application for Linhaliq to be approved for the treatment ... Read more Treatment may be able prevent the progressive accumulation of scar tissue (fibrosis) in newly transplanted lungs that eventually cause those organs to fail, researchers at the University ... Read more Specialists in respiratory syncytial virus (RSV) from the RSV Consortium in Europe received a grant worth 29 million euro (equal to about $30.8 million American) ... Read more In a new study, researchers at The Hospital for Sick Children (SickKids) in Toronto, Canada, analyzed the suitability of pulse oximetry as a decision-making ... Read more New research conducted at the University of Sydney in Australia found that the risk of having an acute myocardial infarction, commonly referred to as a ... Read more The non-profit European Environmental Bureau (EEB) is hailing a European Commission move toward legal action against France, Germany, Italy, Spain and the United Kingdom for ... Read more Olfactory receptors, a group of proteins that are activated by certain odors in the nose, can also be found in bronchi cells, where they ... Read more Devices that remotely monitor COPD patients conditions could help improve their outcomes, a study suggests. A Cedars-Sinai Medical Center team said there were signs in ... Read more Moving chronic obstructive pulmonary disease (COPD) patients from hospitals to their homes could improve the sustainability of Canada s health system while improving individual outcomes, says ... Read more New York City s Montefiore Einstein Center for Heart Vascular Care has received interim approval from the United Network for Organ Sharing (UNOS) to launch its ... Read more Researchers have identified two types of lung cells, one with regenerative features and the other with scar-forming characteristics, according to a study published in ... Read more Researchers have linked the presence of antibodies against the Aspergillus fumigatus (A fum) fungus with the development of bronchiectasis in people with COPD. The study, Sensitization ... Read more Toby Maher, MD, a professor at Imperial College London and based at the National Heart and Lung Institute, is one of three researchers who were awarded the ... Read more The U.S. Food and Drug Administration (FDA) has approved the third targeted therapy developed by Vertex Pharmaceuticals for patients with cystic fibrosis (CF). Symdeko can ... Read more Vertex Pharmaceuticals has selected two of its next-generation correctors, VX-659 and VX-445, for Phase 3 trial development as part of two triple combination regimens for ... Read more The European Commission has granted Vertex Pharmaceuticals an extension of the marketing authorization for Orkambi (lumacaftor/ivacaftor) to include children 6-11 years ... Read more The drug development arms of two leading cystic fibrosis (CF) organizations, one in the U.S. and one in Europe, have endorsed Proteostasis Therapeutics’ coming ... Read more During 2017 Lung Disease News provided you with daily coverage on research, clinical trials and other developments in lung diseases. Here are our top ... Read more Kalydeco (ivacaftor) was shown to be safe and well-tolerated in 1- and 2-year-old children with cystic fibrosis (CF), based on data from a ... Read more Specialists in respiratory syncytial virus (RSV) from the RSV Consortium in Europe received a grant worth 29 million euro (equal to about $30.8 million American) ... Read more Olfactory receptors, a group of proteins that are activated by certain odors in the nose, can also be found in bronchi cells, where they ... Read more Pulmonx recently announced positive results from the IMPACT (NCT02025205) study assessing the company s proprietary Zephyr endobronchial valve (EBV), showing that patients with homogeneous emphysema benefit ... Read more Pulmonx recently announced that its StratX Lung Analysis Platform is commercially available in countries requiring CE mark (Conformité Européne, a mark that proves a ... Read more Pulmonary complications can mount in childhood survivors of cancer for as long as 25 years after initial diagnosis, and have a substantial impact on their ... Read more A team of researchers from the Center for Regenerative Medicine (CReM) of Boston University and Boston Medical Center (BMC) developed a new treatment approach ... Read more PBI-4050, Prometic Life Sciences  lead small molecule therapy candidate, targets a new antifibrotic pathway involving two receptors that play opposite roles in fibrosis development, ... Read more Researchers found that an enzyme previously linked only to cell metabolism is capable of reaching the nucleus of lung fibroblasts and once there, halting ... Read more An investigative drug developed by Kadmon called KD025 was shown to be safe and effective to prevent lung function decline in patients with idiopathic pulmonary ... Read more The digital healthcare company patientMpower expressed disappointment at the opinion issued by an influential U.K. healthcare advisory group to limit the use of Esbriet ... Read more The Pulmonary Fibrosis Foundation has created an online Clinical Trial Finder to help pulmonary fibrosis patients search for trials to enroll in. Foundation officials said the site ... Read more A Vanderbilt University team will study whether adding a commonly used antiviral medicine to standard treatments for idiopathic pulmonary fibrosis can help stop or reverse ... Read more A new blood test can screen for eight cancer types and help spot the tumor location, a recent study from Johns Hopkins Kimmel Cancer ... Read more Insurance status for people in the U.S. with non-metastatic small-cell lung cancer (SCLC) can determine both the type of treatment they are given and ... Read more Cancer mortality rates in the United States have continued to steadily decline, with 2.4 million fewer cancer-related deaths reported in 2015 than in 1991, when ... Read more During 2017 Lung Disease News provided you with daily coverage on research, clinical trials and other developments in lung diseases. Here are our top ... Read more A group of clinician-reseachers with expertise in lung diseases suggest in a commentary that people with both idiopathic pulmonary fibrosis (IPF) and lung cancer are best ... Read more Progression-free survival (PFS) was improved in patients with advanced non-squamous non-small cell lung cancer (NSCLC) using a combination of Avastin (bevacizumab), Tecentriq (atezolizumab), and ... Read more Vibativ (telavancin) displays more punch against the Staphylococcus aureus bacteria that is involved in lung diseases than other antibiotics it has been tested against, according to presentations ... Read more August is National Immunization Awareness Month, and the American Lung Association is reminding adults with serious lung diseases that the Centers for Disease Control ... Read more Aridis Pharmaceuticals has begun enrolling patients in what it says will be a pivotal clinical trial of its antibiotic-resistant pneumonia therapy Aerucin. The trial will cover ... Read more New research conducted at the University of Sydney in Australia found that the risk of having an acute myocardial infarction, commonly referred to as a ... Read more Widespread use of antibiotics in newborns may interfere with gut bacteria, increasing the risk of the infants developing pneumonia, according to a study. The ... Read more A professor at Boston University School of Medicine (BUSM) has been awarded a $5.9 million Outstanding Investigator grant from the National Institutes of Health ... Read more Eiger BioPharmaceuticals will discontinue the development of ubenimex as a therapy for pulmonary arterial hypertension (PAH) due to disappointing results in the Phase 2 LIBERTY ... Read more A Phase 2b clinical study evaluating INOpulse as a treatment for pulmonary hypertension (PH) associated with interstitial lung disease (PH-ILD) enrolled the first patient, ... Read more The Pulmonary Hypertension Association of Canada is conducting a Life in Purple Challenge this month as part of its efforts to mark November as Pulmonary Hypertension Awareness ... Read more The U.S. Food and Drug Administration rejected SteadyMed’s new drug application (NDA) for Trevyent (treprostinil), a treatment for pulmonary arterial hypertension (PAH). According to ... Read more Harbor-UCLA Medical Center in Torrance, California, and Phoenix-based Arizona Pulmonary Specialists — the largest U.S. private practice treating pulmonary hypertension — now offer a digital platform designed ... Read more Researchers from New York s Mount Sinai have partnered with Theragene Pharmaceuticals to further develop a new airway-delivered gene therapy for pulmonary hypertension (PH). After showing promising results in animal studies, this ... Read more In the majority of patients with systemic sclerosis (SSc), interstitial lung disease (ILD) is the leading cause of death. New research shows that plasma ... Read more Cytori Therapeutics provided a recent update on results from clinical trials assessing the use of Cytori Cell Therapy (ECCS-50) in the treatment of scleroderma-related hand dysfunction. The ... Read more Cell therapy company Cytori Therapeutics announced that its Phase 3 STAR clinical trial has enrolled and treated its 60th patient, reaching 75 percent of the target ... Read more Cumberland Pharmaceuticals recently added Vasculan to its clinical portfolio. The company has began the clinical development of Vasculan (ifetroban) oral capsule for the treatment ... Read more Fibrocell Science, Inc., recently announced that the U.S. Food and Drug Administration (FDA) has designated  FCX-013 an orphan drug for the potential treatment of localized ... Read more A new study from researchers in South Carolina report that a small protein called M10 peptide might prevent fibrosis (scarring) in people with systemic sclerosis ... Read more We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more

TAGS:Lung Disease News 

<<< Thank you for your visit >>>

Hot Websites